[HTML][HTML] Biomarkers of inflammation and immune function and risk of colorectal cancer

A Garcia-Anguita, A Kakourou, KK Tsilidis - Current colorectal cancer …, 2015 - Springer
… A recent nested case-control study in the EPIC cohort studied the association of neopterin,
a biomarker of cellular immune activity, with the risk of colorectal cancer and found evidence …

[HTML][HTML] Immune battle at the premalignant stage of colorectal cancer: Focus on immune cell compositions, functions and cytokine products

G Cui - American Journal of Cancer Research, 2020 - ncbi.nlm.nih.gov
… Myeloid-derived suppressor cells (MDSCs) can significantly dampen host antitumor
immune function and promote tumor development. Possible mechanisms include enhanced …

[HTML][HTML] Colorectal cancer and immunity: what we know and perspectives

S Pernot, M Terme, T Voron, O Colussi… - World Journal of …, 2014 - ncbi.nlm.nih.gov
… major escape mechanisms to antitumor immune response. The … immune response, but also
to the use of immunotherapy. Although immunotherapy is not yet routinely used in colorectal

Innate immune function after breast, lung, and colorectal cancer surgery

MF Ramirez, D Ai, M Bauer, JN Vauthey… - Journal of Surgical …, 2015 - Elsevier
… the magnitude of this immune suppression is similar among different types of oncological
surgery. In this study, we compared the innate immune function of patients undergoing three …

The colorectal cancer immune microenvironment and approach to immunotherapies

M Koi, JM Carethers - Future Oncology, 2017 - Taylor & Francis
tumor angiogenesis, tumor invasion and immune suppression, and contribute to an
immune suppressive tumor … MCs in cancer promote angiogenesis and tumor invasion into …

[HTML][HTML] Immune checkpoints as a target for colorectal cancer treatment

A Passardi, M Canale, M Valgiusti, P Ulivi - International journal of …, 2017 - mdpi.com
… We present an updated review of the biological background and clinical development of
immune checkpoint inhibitors in colorectal cancer (CRC). Early trial results on PD1 and PD-L1 …

Impact of perioperative blood transfusion on immune function and prognosis in colorectal cancer patients

L Qiu, DR Wang, XY Zhang, S Gao, XX Li… - … and apheresis science, 2016 - Elsevier
… In our study, we investigated the impact of perioperative blood transfusion on the immune
function and prognosis in hereditary colorectal cancer (HCC) and SCC patients. By comparing …

[HTML][HTML] The role of the immune system in IBD-associated colorectal cancer: from pro to anti-tumorigenic mechanisms

S Frigerio, DA Lartey, GR D'haens… - International journal of …, 2021 - mdpi.com
… mechanisms may contribute to tumorigenesis by impairing anti-tumor immunity. This review
will delineate the role of the immune system in IBD-associated cancer with a particular focus …

[HTML][HTML] Immune landscape of colorectal cancer tumor microenvironment from different primary tumor location

L Zhang, Y Zhao, Y Dai, JN Cheng, Z Gong… - Frontiers in …, 2018 - frontiersin.org
… To define differences in tumor microenvironment (TME) immune phenotypes between
right and left colorectal cancers (CRCs) and explore their therapeutic implications. Gene …

Immune cells in colorectal cancer: prognostic relevance and therapeutic strategies

I Atreya, MF Neurath - Expert review of anticancer therapy, 2008 - Taylor & Francis
… ’s fate and determine, by their complex functional interactions, whether or not the progress
… setting of colorectal cancer and highlights the functional mechanisms of those immune cells …